- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic therapy and outcome from immune-checkpoint inhibitors
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-07
DOI
10.1186/s40425-019-0775-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer
- (2019) Taiki Hakozaki et al. Oncology Letters
- A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
- (2019) Alessio Cortellini et al. Journal for ImmunoTherapy of Cancer
- Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
- (2019) Arielle Elkrief et al. OncoImmunology
- Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
- (2019) Uqba Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
- (2019) Rossella Cianci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
- (2019) Sha Zhao et al. LUNG CANCER
- Metabolism at the centre of the host–microbe relationship
- (2019) K. M. Maslowski CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer
- (2019) Giulia Galli et al. LUNG CANCER
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
- (2019) Clara Depommier et al. NATURE MEDICINE
- Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
- (2019) Julia Ouaknine Krief et al. Journal for ImmunoTherapy of Cancer
- The prognostic role of obesity is independent of sex in cancer patients treated with immune checkpoint inhibitors: A pooled analysis of 4090 cancer patients
- (2019) Huilin Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
- (2019) Giovanni Rossi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC).
- (2018) Aly-Khan A. Lalani et al. JOURNAL OF CLINICAL ONCOLOGY
- The gut microbiota influences anticancer immunosurveillance and general health
- (2018) Bertrand Routy et al. Nature Reviews Clinical Oncology
- Disruption of the Gut Ecosystem by Antibiotics
- (2018) Mi Young Yoon et al. YONSEI MEDICAL JOURNAL
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
- (2018) Florian Huemer et al. Oncotarget
- Cumulative antibiotic use and efficacy of immune checkpoint inhibitors in patients with advanced cancer.
- (2018) Nadina Tinsley et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
- (2018) Tien Phuc Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors
- (2018) Jibran Ahmed et al. OncoImmunology
- Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
- (2017) Lisa Derosa et al. JOURNAL OF CLINICAL ONCOLOGY
- P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors
- (2017) J. Thompson et al. Journal of Thoracic Oncology
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cancer and the gut microbiota: An unexpected link
- (2015) Laurence Zitvogel et al. Science Translational Medicine
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Antibiotics, microbiota, and immune defense
- (2012) Carles Ubeda et al. TRENDS IN IMMUNOLOGY
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
- (2010) L. Dethlefsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started